Copyright
©The Author(s) 2016.
World J Diabetes. Dec 15, 2016; 7(20): 615-620
Published online Dec 15, 2016. doi: 10.4239/wjd.v7.i20.615
Published online Dec 15, 2016. doi: 10.4239/wjd.v7.i20.615
Figure 1 Difference between serum brain-derived neurotrophic factor levels between control subjects and patients in hemodialysis therapy patients with diabetes mellitus type 2.
BDNF: Brain-derived neurotrophic factor; HD: Hemodialysis therapy; DM2: Diabetes mellitus type 2.
- Citation: Murillo Ortíz B, Ramírez Emiliano J, Ramos-Rodríguez E, Martínez-Garza S, Macías-Cervantes H, Solorio-Meza S, Pereyra-Nobara TA. Brain-derived neurotrophic factor plasma levels and premature cognitive impairment/dementia in type 2 diabetes. World J Diabetes 2016; 7(20): 615-620
- URL: https://www.wjgnet.com/1948-9358/full/v7/i20/615.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i20.615